Serving the rare disease community goes beyond developing precision genetic medicines. Sarepta is committed to providing support at every stage of a patient’s journey. Our partnerships with patient advocacy groups are fundamental to this work.
We provide grants, donations, medical education support, and sponsorships to advocacy groups, nonprofit organizations, academic institutions, scientific and medical associations, continuing medical education providers, and other organizations across the spectrum of neuromuscular and rare diseases, with priority assigned to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company.